Dexmedetomidine and Agitation After Nasal Surgery

Recruiting now · Not applicable

Conditions studied: Nasal Disease, Agitation, Emergence

In brief

The main objective of study is to compare dexmedetomidine single bolus dose before extubation with continuous infusion as regards their efficacy in mitigating the incidence of emergence agitation in obese adults undergoing nasal surgery.

Key facts

Study ID

NCT06867302

Run by

Fayoum University Hospital

People needed

50

Starts

2025-03-01

Expected to finish

2025-10-01

Last updated by the study team

2025-03-10

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• American Society of Anesthesiologist (ASA) Ⅰ or II
• Adults with body mass index (BMI) < 30 Kg/m
• Underwent elective nasal surgery.

You may not qualify if…

• Significant comorbidity like hepatic, renal, or cardiac disease
• Auditory impairment
• Cognitive dysfunction
• Substance abuse
• Allergy to the studied medicines
• Planned intensive care admission after the surgery.

Where it is running

• Fayoum University Hospital — Al Fayyum, Faiyum Governorate, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.